3 Stocks I Saw on T...
Health Care: Drugs
Cytori Therapeutics Inc. (CYTX: NASDAQ)
$2.13 0.05 | 2.40%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 36.92M | 52.67M | 12.85M | 12.61M |
| Receivables | 2.26M | 2.07M | 1.63M | 1.62M |
| Inventories | 3.32M | 3.38M | 2.59M | 2.14M |
| Other Current Assets | 837.00K | 834.00K | 1.02M | 252.00K |
| Total Current Assets | 43.34M | 58.95M | 18.10M | 17.22M |
| Property, Plant & Equipment, Gross | 9.70M | 9.30M | 8.25M | 8.79M |
| Accumulated Depreciation & Depletion | 7.99M | 7.61M | 6.94M | 6.23M |
| Property, Plant & Equipment, Net | 1.71M | 1.68M | 1.31M | 2.55M |
| Intangibles | 192.00K | 413.00K | 635.00K | 857.00K |
| Other Non-Current Assets | 2.37M | 1.38M | 780.00K | 1.05M |
| Total Non-Current Assets | 8.20M | 7.39M | 6.65M | 8.38M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 51.53M | 66.35M | 24.75M | 25.61M |
| Accounts Payable | 272.00K | 6.77M | 1.31M | 464.00K |
| Short Term Debt | 2.49M | 6.45M | 2.70M | 2.05M |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 328.00K |
| Total Current Liabilities | 7.82M | 13.22M | 8.18M | 7.14M |
| Long Term Debt | 21.96M | 0.00 | 2.79M | 5.04M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 11.80M | 17.00M | 17.43M | 21.15M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 33.77M | 30.25M | 20.22M | 26.19M |
| Total Liabilities | 41.59M | 43.47M | 28.41M | 33.33M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 9.95M | 22.87M | -3.66M | -7.72M |
| Common Par | 57.00K | 52.00K | 40.00K | 31.00K |
| Additional Paid In Capital | 252.34M | 232.82M | 178.81M | 161.21M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -242.45M | -210.00M | -182.50M | -162.17M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | -6.79M |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 31.91M | 22.87M | -868.00K | -2.67M |
| Total Equity | 9.95M | 22.87M | -3.66M | -7.72M |
| Total Liabilities & Stock Equity | 51.53M | 66.35M | 24.75M | 25.61M |
| Total Common Shares Outstanding | 56.59M | 51.96M | 40.04M | 29.30M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 1.87M |
| Basic Weighted Shares Outstanding | 53.50M | 45.95M | 35.94M | 26.88M |
| Diluted Weighted Shares Outstanding | 53.50M | 45.95M | 35.94M | 26.88M |
| Number of Employees | 128 | 124 | 93 | 126 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CYTX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor6 Drug Stocks Unworthy of B...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorStem Cell Stocks
- Usermurphman Portfolio 1
- UserSUPRATRADE HOT STOCKS (BUY ...
Latest CYTX Headlines from TheStreet
- 8 Stocks Under $10 Soaring Higher 05.10.12 | 01:05 pm
- Tuesday's Top 10 Articles, Videos on TheStreet 02.07.12 | 01:02 pm
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
- Cytori Therapeutics Inc. (CYTX): Today's Featured Drugs Loser 09.29.11 | 04:09 pm
- Biotech Stock Mailbag: Mela Sciences 09.09.11 | 06:09 am
- Biotech Stock Mailbag: Cytori Therapeutics 05.20.11 | 07:05 am
- Cytori Therapeutics Inc. Stock Downgraded (CYTX) 05.10.11 | 06:05 am
- Cytori Stock Hits New 52-Week High (CYTX) 04.04.11 | 10:04 am
- Cytori Therapeutics Inc. Stock Upgraded (CYTX) 03.24.11 | 06:03 pm
Press Releases for CYTX
- Cytori Therapeutics Announces Independent Clinical Study Results In Breast Reconstruction Presented At The Association Of Breast Surgery Conference - Business Wire 05.17.11 | 05:05 am
- Catholic Healthcare West President/CEO Lloyd H. Dean To Join Cytori Therapeutics’ Board Of Directors - Business Wire 11.03.10 | 07:11 am
- Cytori Announces Exercise In Full Of Overallotment Option And Closing Of Public Offering Of Common Stock; Raises $19.3 Million In Net Proceeds - Business Wire 10.13.10 | 09:10 am
- Cytori Therapeutics Prices Public Offering Of Common Stock - Business Wire 10.08.10 | 08:10 am
- Cytori Therapeutics Proposes Common Stock Public Offering - Business Wire 10.07.10 | 04:10 pm
- Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Function In Preclinical Acute Kidney Injury Study Data Published Today - Business Wire 10.05.10 | 08:10 am
- Cytori Extends Distribution Agreement With GE Healthcare; Key Focus On Research Market - Business Wire 09.16.10 | 07:09 am
- Cytori Therapeutics Announces Fall 2010 U.S. Conference Schedule - Business Wire 09.13.10 | 07:09 am
- Cytori Issued Celution® System Patent For Orthopedic & Spinal Disc Diseases - Business Wire 08.12.10 | 07:08 am
- Cytori’s PureGraft™ System Receives European Approval For Fat Grafting Procedures - Business Wire 07.29.10 | 08:07 am
Partner Headlines for CYTX
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No - Seeking Alpha 05.06.11 | 03:05 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- 9 Cheap Stocks Under $10 Making New Price Highs - Seeking Alpha 03.25.11 | 08:03 am
- Options Brief: Cytori Therapeutics (CYTX) - Benzinga 03.17.11 | 01:03 pm
- UPDATE 1-Cytori, Astellas Pharma sign $10 mln equity deal - Reuters 12.07.10 | 07:12 am
